SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
GHDx Entry last modified on: Apr 10, 2023
COVID-19
Dataset Records for COVID-19
Displaying 51 - 100 of 1229
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.1.7
GHDx Entry last modified on: Sep 9, 2022
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients
GHDx Entry last modified on: Apr 10, 2023
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
GHDx Entry last modified on: Apr 10, 2023
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.351
GHDx Entry last modified on: Sep 9, 2022
Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. Preprint
GHDx Entry last modified on: May 12, 2022
A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
Brazil - Tocantins COVID-19 Epidemiological Bulletin 2021
Boletim Epidemiológico Notificação para COVID-19 2021
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.525
GHDx Entry last modified on: Sep 9, 2022
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
GHDx Entry last modified on: May 12, 2022
Benin Health Statistical Yearbook 2021
Annuaire Des Statistiques Sanitaires Annee 2021
Report:
Epi surveillance - Nationally representative - Urban-rural representative
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1
GHDx Entry last modified on: Sep 9, 2022
Changes in depression and suicidal ideation under severe lockdown restrictions during the first wave of the COVID-19 pandemic in Spain: A longitudinal study in the general population
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Canada - Ontario Daily Epidemiological Summary of COVID-19 2021
Epidemiologic Summary COVID-19 in Ontario
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint
GHDx Entry last modified on: Apr 8, 2022
Italy Open Data on COVID-19 Vaccines 2020-2022
covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries 2020-2022
Epi surveillance:
Health facility - Subnationally representative
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility 2020-2022
COVID-19 Reported Patient Impact and Hospital Capacity by Facility
Epi surveillance:
Health facility
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Australia Household Impacts of Covid-19 Survey November 2020
Survey:
Longitudinal
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint
GHDx Entry last modified on: May 12, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020
RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020
Epi surveillance:
Subnationally representative
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020
Survey:
Health facility - Individual - Interview - Longitudinal
Subscribe